Table 1.
T3359 CD133+ | ||
---|---|---|
Treatment | 10,000 cells | 1,000 cells |
Control (DMSO) | Incidence: 3/3 Median Survival: 24 days |
Incidence: 3/3 Median Survival: 35 days |
25 uM AktIII inhibitor | Incidence: 3/3 Median Survival: 40 days |
Incidence: 2/3 Median Survival: 66 days |